Treatments:Diabetes
From Proteopedia
(Difference between revisions)
(→Glucagon-like peptide-1 (GLP-1) agonist) |
|||
| Line 20: | Line 20: | ||
*[[Metformin]] - Generic: [[N,N-dimethylbiguanide]] | *[[Metformin]] - Generic: [[N,N-dimethylbiguanide]] | ||
=====Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)===== | =====Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)===== | ||
| - | *[[Empagliflozin]] | + | *[[Empagliflozin]] - Generic: Jardiance |
*[[Canagliflozin]] | *[[Canagliflozin]] | ||
*[[Dapagliflozin]] | *[[Dapagliflozin]] | ||
Current revision
Insulin
Dipeptidyl peptidase IV Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
Glucagon-like peptide-1 (GLP-1) agonist
Mechanism is not completely understood
Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)
|
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
